株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の製薬会社とバイオテクノロジー企業の提携分析

Global Pharma-biotech Alliance Analysis

発行 Frost & Sullivan 商品コード 119503
出版日 ページ情報 英文 77 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
世界の製薬会社とバイオテクノロジー企業の提携分析 Global Pharma-biotech Alliance Analysis
出版日: 2010年05月14日 ページ情報: 英文 77 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当レポートでは、2008年以降の世界の製薬会社とバイオテクノロジー企業の提携取引の概要について分析し、治療分野別、製品開発段階別、契約形態別に検証し、主要ベンダーの詳細なプロファイルなども織り交ぜ、概略以下の構成でお届けします。

  • 製薬会社とバイオテクノロジー企業の提携のイントロダクション
  • 課題、促進因子、阻害因子
  • 契約の概要
  • 治療分野別契約概要
  • 開発段階別契約概要
  • 企業別契約概要
  • 将来の方向性
  • Frost & Sullivanについて
目次
Product Code: M5C3

Abstract

This IBD provides an overview of the pharma-biotech alliance deals struck from 2008 to present. This study covers deal structures by therapeutic area, stage of product development and deal type. Trends in alliances from selected pharmaceutical companies are also analyzed. This report provides detailed profiles of the key vendors in the industry such as AstraZeneca; Novartis AG; Roche; Merck; Pfizer; Sanofi-Aventis; Amgen and GSK. Within each company segment analysis, an in-depth analysis of the competitive situation, a therapeutic area wise focus and an analysis of top deals in the last two years is included. Finally, this study presents the market overview and summary of key findings.

Table of Contents

Pharma-biotech Alliances

  • Introduction to Pharma-biotech Alliances
  • Challenges, Drivers and Restraints
  • Overview of Deals
  • Overview of Deals by Therapeutic Area
  • Overview of Deals by Stage of Development
  • Overview of Deals by Selected Companies
  • Future Direction
  • About Frost & Sullivan

Global Pharma-biotech Alliances

  • Pharma-biotech Alliances: Industry Challenges (World), 2010-2016
  • Pharma-biotech Alliances: Impact Probability Matrix for Challenges (World), 2010-2016
  • Pharma-biotech Alliances: Market Drivers (World), 2010-2016
  • Pharma-biotech Alliances: Market Restraints (World), 2010-2016
  • Pharma-biotech Alliances: Impact Mapping of Global Pharma-biotech Alliance Drivers and Restraints (World), 2010-2016
  • Pharma-biotech Alliances: Deal Volume for Pharma-Biotech M&A and Licensing Deals (World), 2009-2010
  • Pharma-biotech Alliances: Deal Type Break-up for Pharma-biotech Licensing Deals (World), 2005-2009
  • Pharma-biotech Alliances: Deal Analysis by Therapeutic Area (World), 2008-2010
  • Pharma-biotech Alliances: Percentage of Partnered Products By Stage of Drug Development (World), 2010
  • Pharma-biotech Alliances: AstraZeneca - Percentage of Partnered Products Versus Average Sales (World), 2008-2009
  • Pharma-biotech Alliances: Percentage of Drug Candidates by Phase of Drug Development (World), 2010
  • Pharma-biotech Alliances: AstraZeneca Potential Drug Candidates Filings (World), 2009-2014
  • Pharma-biotech Alliances: Percentage of Partnered Product in Pipeline (World), 2010
  • Pharma-biotech Alliances: Drug Candidates from Alliances (World), 2008 and 2009
  • Pharma-biotech Alliances: Novartis - Percentage of Partnered Products Versus Average Sales (World), 2008 and 2009
  • Pharma-biotech Alliances: Novartis - Percentage of Partnered Products in Drug Pipeline by Therapeutic Area (World), 2009Pharma-biotech Alliances: Novartis - Percentage of Partnered Product in Pipeline by Therapeutic Area (World), 2009
  • Pharma-biotech Alliances: Drug Candidates from Alliances and Partnerships (World), 2010
  • Pharma-biotech Alliances: Roche: Analysis of Deals Types (World), 2005-2008
  • Pharma-biotech Alliances: Roche - Percentage of Partnered Products Versus Average Sales (World), 2008
  • Pharma-biotech Alliances: Percentage of Partnered Compounds by Phase of Drug Development (World), 2010
  • Pharma-biotech Alliances: Percentage of Total Drug Candidates by Phase of Drug Development (World), 2010
  • Pharma-biotech Alliances: Percentage Of Drug Candidates In Pipelines (World), 2010
  • Pharma-biotech Alliances: Licensing Deals by Therapeutic Area (World), 2008-2010
  • Pharma-biotech Alliances: Drugs in Development by Therapeutic Area (World), 2008-2010
  • Pharma-biotech Alliances: Merck - Percentage of Partnered Products Versus Average Sales (World), 2008-2009
  • Pharma-biotech Alliances: Current Drug Candidates in Product Pipeline (World), 2010
  • Pharma-biotech Alliances: Revenues Obtained from Sales of Pfizer Products By Year (World), 2007-2009
  • Pharma-biotech Alliances: Percentage of Partnered Drug Candidates by Therapeutic Area (World), 2008-2010
  • Pharma-biotech Alliances: Percentage of Drug Candidates in Various Therapeutic Areas by Stage of Drug Development (World), 2010
  • Pharma-biotech Alliances: Molecules from Partnerships as of April 2009
  • Pharma-biotech Alliances: Current Drug Candidates in Product Pipeline (World), 2010
Back to Top